MATERNAL HEALTH CHALLENGE; NIGERIA
PROVEN INTERVENTION TO BE DISTRIBUTED
Misoprostol.
Learn more about the Maternal Health Challenge and how the distribution of Misoprostol, a $3 drug that can prevent maternal deaths from postpartum hemorrhage, could save thousands of lives.
DISTRIBUTION MODEL INNOVATION
Ending Maternal Mortality (EMM) reduces maternal mortality through training birth attendants and distributing life-saving medical treatments.
The EMM model begins with upskilling informal health workers (e.g. traditional birth attendants) and connecting them with upskilled formal healthcare workers (e.g. community health workers) to promote the use of misoprostol in rural Nigeria. Health workers pre-register women via a simple prescription process and user registration form. This registration gives women access to misoprostol should they give birth at a healthcare facility or with an upskilled birth attendant.
EMM was founded by a team of ambitious 17-year-old young women in 2020. Ruhani Walia and Isabella Grandic serve as EMM's project directors. Navya Riju, Sophie Lukashenkova Pellar and Christina Wang are EMM's training upskilling directors.
PILOT AND SCALING GOALS
Directly register 1,400 women during the pilot phase
Using 100 trained TBAs, distribute 1400 doses of misoprostol during the pilot phase (1 dose = 3-4 pills)
Secure $10,000 USD in further funding within first three months
Reach 7,000 women by the end of year 1
Reach 18,000 women by the end of year 2
FOUNDING TEAM
Isabella Grandic - Project Director
Ruhani Walia - Project Director
Navya Riju - Medical Training Director
Sophie Lukashenkova Pellar - Medical Training Director
Christina Wang - Pictorial Training Director